Biocon Soars Nearly 10% On Receiving Nod For Covid-19 Drug

Biocon received approval from the Drugs Controller General of India to market its novel biologic drug Itolizumab for treatment of patients with moderate to severe Covid-19 complications.

from NDTV Profit - Latest https://ift.tt/32cuDda